Neuralink, owned by Elon Musk, announced Thursday that it received FDA approval to begin its first human clinical trial.
The company is developing a brain implant called the Link in efforts to help patients with severe paralysis regain their abilities to communicate.
“We are excited to share that we have received the FDA’s approval to launch our first-in-human clinical study! This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our technology to help many people,” Neuralink wrote on Twitter.
“Recruitment is not yet open for our clinical trial. We’ll announce more information on this soon!” the company added.
We are excited to share that we
Join the conversation!
Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!